A Medical Research Study to Evaluate the Effects of ACT-246475 in Adults With Heart Attack

NCT03487445 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

48

Enrollment

INDUSTRY

Sponsor class

Conditions

Acute Myocardial Infarction

Interventions

DRUG: Selatogrel 8 mg
DRUG: Selatogrel 16 mg

Sponsor

Viatris Innovation GmbH